Methylnaltrexon påvirker ikke farmakokinetikken af lægemidler, der metaboliseres af cytokrom P450 (CYP) - isozymer.
Methylnaltrexone does not affect the pharmacokinetics of medicinal products metabolised by cytochrome P450 (CYP) isozymes.